Replies to post #274352 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

Christopher U. Missling MS PhD MBA holds at least 1,018,210 shares of AVXL stock and hasn't sold a share.

Good luck and GOD bless,

[XenaLives]

With options, Missling has more stock than any single institution or shareholder.

Believe me, he is fully invested and has been for years.

Missling and SAVA CEO both own around 8%.


Your point is moot...

I don't know much about SAVA's competing drug to A-273, but I can tell that SAVA has a significantly better CEO who is willing to make a large insider purchase -- something Missling has yet to do on a regular basis.